Massachusetts General Hospital
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Massachusetts General Hospital sits in the top decile of US sponsors by registered trial count (#4 of 15,751 sponsors by registered trial count).
Massachusetts General Hospital: 2,032 sponsored US clinical trials, 336 recruiting.
Massachusetts General Hospital sponsors 2,032 registered US clinical trials on ClinicalTrials.gov, 336 of them currently recruiting, and 1,284 completed. 240 of these trials are in Phase 3-4 (later-stage) and 515 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 29 trials.
Top-decile sponsor footprint
Massachusetts General Hospital ranks in the top decile of sponsors by registered trial count (#4 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
2,032 total, page 38 of 41
Hormone Dynamics and Bone Mineral Density in Anorexia Nervosa v. Hypothalamic Amenorrhea
NCT00556036
Study of SU11248 in Men With Advanced Prostate Cancer
NCT00299741
Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder
NCT00282828
Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer
NCT00387348
The Treatment of Insomnia in Symptomatic Peri- and Postmenopausal Women
NCT00374192
A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia
NCT00455715
Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus
NCT00403533
Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder
NCT00374543
A Study of Repeat Dosing of OROS® Methylphenidate Hydrochloride (CONCERTA®) and Immediate Release Methylphenidate Hydrochloride in Healthy Adults
NCT00302458
Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa
NCT00283595
CMC Arthritis - Neoprene Vs. Thermoplast Short Opponens Splinting
NCT00438763
A Clinical Trial of Splinting for DeQuervain's Tenosynovitis
NCT00438191
Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD)
NCT00464698
Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia
NCT01576640
Effectiveness of a Computer Application in Improving Pulmonary Artery Catheter Waveform Interpretation
NCT00138073
Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents With Bipolar Disorder
NCT00592852
Understanding Experimentally Induced Hot Flushes
NCT00455689
Memantine and Cognitive Dysfunction in Bipolar Disorder
NCT00586066
The Development and Evaluation of an "E-Visit" Program for the Management of Acne
NCT00417456
Effectiveness of Behavior Therapy and Psychosocial Therapy for the Treatment of Tourette Syndrome and Chronic Tic Disorder
NCT00231985
Gefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT00411047
Use of NT-proBNP Testing to Guide Heart Failure Therapy in the Outpatient Setting.
NCT00351390
Study of the Effects of Risperdal Consta on Brain Reward Circuitry Function, Craving and Cocaine Use in Active Cocaine Dependence
NCT00385801
EEG Studies of Induction and Recovery From Propofol Induced General Anesthesia
NCT01543633
Bipolar Disorder in Pregnancy and the Postpartum Period: Predictors of Morbidity
NCT00580268
Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus
NCT00133367
Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding
NCT00445653
Pharmacokinetics of Curcumin in Healthy Volunteers
NCT00181662
Equetro for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder
NCT00181870
Calcium Supplementation for a Healthy Weight (CaSHeW)
NCT01363115
Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon
NCT00694122
Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder
NCT00120250
Splinting for Dupuytren's Contracture Release
NCT00575458
Evaluation of Computer-assisted, Non-cathartic CT Colonography
NCT01200303
SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and PTSD in Physical Trauma Victims
NCT00114374
Study of Velcade and Thalidomide in Patients With Myelodysplasia
NCT00271804
Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature
NCT00121875
Rule Out Myocardial Infarction by Computer Assisted Tomography
NCT00990262
Family Risk Analysis of Substance Use in Attention Deficit Hyperactivity Disorder (ADHD) Youth Treated With Concerta
NCT00181792
Neuroendocrine Modulation of Metabolic Effects in Overweight Adolescents
NCT00140842
Effectiveness of Escitalopram in the Treatment of Body Dysmorphic Disorder
NCT00149799
Effectiveness of Acupuncture for Depressed Patients Not Taking Antidepressant Medications
NCT01634022
Aripiprazole for the Treatment of Refractory Anxiety
NCT00438386
Creatine Safety & Tolerability in Huntington's Disease
NCT01412151
Imuran (Azathioprine) Dose-Ranging Study in Crohn's Disease
NCT00098111
Improving Pediatric Safety and Quality With Health Care Information Technology
NCT00134823
A PET Study Examining Pharmacokinetics and Dopamine Transporter Receptor Occupancy Of Two Long-Acting Formulations of Methylphenidate in Adults
NCT00301639
Effectiveness of Aripiprazole for Improving Side Effects of Clozapine in the Treatment of People With Schizophrenia
NCT00345033
Pilot Study of Bupropion for Smoking Cessation in Postpartum Non-breastfeeding Women
NCT00119210
An Intervention to Address Parental Smoking During the Postpartum Hospitalization.
NCT00844818
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 226 |
| Phase 2 | 289 |
| Phase 3 | 58 |
| Phase 4 | 182 |
Therapeutic Areas
What is open in the Massachusetts General Hospital pipeline
336 recruiting of 2,032 indexed (17% open); 1,284 completed (63%).
Phase mix: 240 late (III/IV) vs 515 early (I/II) (early-phase heavy).
Top condition: Depression (29 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.